GLP-1 Drug Comparison Tool — Ozempic vs Wegovy vs Mounjaro vs Zepbound

Q: Is Mounjaro better than Ozempic for weight loss?

On average, yes. Tirzepatide produces approximately 20–22% total body weight loss versus 12–15% for semaglutide at approved doses.

Q: What is the difference between Mounjaro and Zepbound?

They contain the same active ingredient — tirzepatide — at the same doses, with different FDA indications.

Q: Which GLP-1 medication has the fewest side effects?

All four have similar GI side effect profiles. Tirzepatide may have slightly lower nausea rates at comparable efficacy levels.

Q: Can I switch from Ozempic to Mounjaro?

Yes, with prescriber guidance. Your doctor will determine the appropriate starting dose for the new medication.

Semaglutide vs Tirzepatide: The Core Difference

The most important distinction in this comparison is the drug class. Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist that activates one hormonal pathway. Mounjaro and Zepbound contain tirzepatide, a dual GIP/GLP-1 receptor agonist that activates two pathways simultaneously.

This dual mechanism is why tirzepatide produces significantly more weight loss on average — roughly 20–22% of body weight versus 15–17% for the highest semaglutide dose. For a 250-pound person, that difference is approximately 12–17 additional pounds lost. See the detailed Semaglutide vs Tirzepatide comparison for a deeper analysis.

Ozempic vs Wegovy: Same Drug, Different Dose

Many people are confused by the fact that both Ozempic and Wegovy contain semaglutide. The key differences are the approved indication and maximum dose. Ozempic is approved for type 2 diabetes at doses up to 2mg weekly. Wegovy is approved for chronic weight management at 2.4mg weekly — a higher dose that produces more weight loss.

Ozempic is widely prescribed off-label for weight loss, but its maximum approved dose (2mg) is lower than Wegovy's maintenance dose (2.4mg). This means Wegovy users typically achieve more weight loss. However, insurance coverage differs significantly — many plans cover Ozempic for diabetes but not Wegovy for weight loss. See our Cost & Insurance guide for details.

Mounjaro vs Zepbound: Same Drug, Different Label

Mounjaro and Zepbound are essentially the same medication — both contain tirzepatide at identical doses — but with different FDA approvals. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. The clinical difference is negligible, but the insurance coverage implications are significant.

Which Drug Should You Choose?

The choice between these medications depends on several factors your doctor will consider: whether you have type 2 diabetes, your insurance coverage, your tolerance for side effects, your weight loss goals, and cost. Generally speaking, tirzepatide produces more weight loss but both drug classes are highly effective. Use our Weight Loss Predictor to estimate your results on each medication.

Frequently Asked Questions

Is Mounjaro better than Ozempic for weight loss?

On average, yes. Tirzepatide (Mounjaro/Zepbound) produces approximately 20–22% total body weight loss versus 12–15% for Ozempic. Wegovy (higher-dose semaglutide 2.4mg) is the more direct comparison at 15–17%. See our Semaglutide vs Tirzepatide comparison for full details.

What is the difference between Ozempic and Wegovy?

Both contain semaglutide but at different doses and for different approved indications. Ozempic is for type 2 diabetes at up to 2mg weekly. Wegovy is for weight management at 2.4mg weekly. Wegovy produces more weight loss due to the higher dose.

What is the difference between Mounjaro and Zepbound?

They contain the same active ingredient — tirzepatide — at identical doses. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for weight management. The clinical difference is negligible but insurance coverage implications differ significantly.

Which GLP-1 medication has the fewest side effects?

All four have similar GI side effect profiles. Clinical data suggests tirzepatide may have slightly lower nausea rates at comparable efficacy levels, but the difference is modest. Individual responses vary significantly. See our Side Effect Timeline Alcohol Interaction Water Intake Calculator Meal Planner for a week-by-week breakdown.

Can I switch from Ozempic to Mounjaro?

Yes, switching is done clinically. Your doctor will determine the appropriate starting dose — typically the initiation dose — rather than an equivalent higher dose. Always consult your prescriber before switching medications.

Are compounded GLP-1 medications from telehealth providers safe?

Compounded GLP-1 medications offered by providers like Ro, Hims & Hers, and others are not FDA-approved and are not subject to the same manufacturing standards as brand-name drugs. Quality, potency, and sterility may vary. They are generally only legally available when FDA-approved versions are on shortage. Always consult a licensed healthcare provider and understand these tradeoffs before choosing a compounded option.

GLP-1 Drug Comparison

Semaglutide vs Tirzepatide: The Core Difference

Ozempic vs Wegovy: Same Drug, Different Dose

Mounjaro vs Zepbound: Same Drug, Different Label

Which Drug Should You Choose?

More GLP-1 Tools

Frequently Asked Questions